hydromorphone and Breakthrough Pain

hydromorphone has been researched along with Breakthrough Pain in 5 studies

Research

Authors	Studies
Chen, H; Huang, C; Li, X; Lin, R; Lin, S; Liu, J; Lu, M; Luo, Y; Lv, X; Su, L; Wu, M; Zhang, Z; Zhao, S; Zhou, M; Zhu, J; Zou, H	1
Mercadante, S	1
Ammar, D; Baron, L; Chvetzoff, G; Collin, E; Delorme, C; Delorme, T; Faure, S; Filbet, M; Hubault, P; Jovenin, N; Krakowski, I; Magnet, M; Michenot, N; Minello, C; Poulain, P; Rostaing, S	1
Ahn, JB; Ahn, JS; Han, HS; Jeon, SW; Kang, JH; Kim, SR; Kim, YC; Kim, YS; Kwon, JH; Lee, KH; Lee, PB; Lee, SY; Lee, WS; Oh, HS; Oh, SY; Park, KT; Park, SW; Ryu, JS; Seol, YM; Yuh, YJ	1
Cruciani, RA; Katz, N; Portenoy, RK	1

1 review(s) available for hydromorphone and Breakthrough Pain

Article	Year
[Opioid switch and change of route of administration in cancer patients treated by morphine]. Bulletin du cancer, 2018, Volume: 105, Issue:11 Topics: Administration, Oral; Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Drug Substitution; Fentanyl; France; Humans; Hydromorphone; Injections, Intravenous; Injections, Subcutaneous; Methadone; Morphine; Oxycodone; Phenols; Tapentadol	2018

3 trial(s) available for hydromorphone and Breakthrough Pain

Article	Year
Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II Trial. Journal of the National Comprehensive Cancer Network : JNCCN, 2022, Volume: 20, Issue:9 Topics: Analgesia, Patient-Controlled; Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Humans; Hydromorphone; Morphine; Neoplasms; Pain Measurement	2022
A prospective, open-label, multicenter study of the clinical efficacy of extended-release hydromorphone in treating cancer pain inadequately controlled by other analgesics. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Breakthrough Pain; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Hydromorphone; Male; Middle Aged; Neoplasms; Pain Measurement; Prospective Studies; Sleep; Treatment Outcome; Young Adult	2014
Dose equivalence of immediate-release hydromorphone and once-daily osmotic-controlled extended-release hydromorphone: a randomized, double-blind trial incorporating a measure of assay sensitivity. The journal of pain, 2012, Volume: 13, Issue:4 Topics: Adult; Aged; Analgesia; Analgesics, Opioid; Breakthrough Pain; Chronic Pain; Double-Blind Method; Female; Humans; Hydromorphone; Male; Middle Aged; Patient Selection	2012

1 other study(ies) available for hydromorphone and Breakthrough Pain

Article	Year
Intrathecal patient-controlled analgesia has nothing to do with breakthrough cancer pain. Pain, 2021, 05-01, Volume: 162, Issue:5 Topics: Analgesia, Epidural; Analgesia, Patient-Controlled; Breakthrough Pain; Cancer Pain; Humans; Hydromorphone; Morphine; Neoplasms; Single-Blind Method	2021